Company / PP&E (Net)
Yubo International Biotech Ltd PP&E (Net) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$43.0K
FY2025
5-year range
$43.0K / $616.7K
FY2021-FY2025
Trend
-79.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has declined for 3 consecutive years, from $616,652 in FY2022 to $43,030 in FY2025.
Based on SEC 10-K filings.
$43,030 in FY2025 with a 5-year CAGR of -11.5%.
Declined from $375,209 to $43,030 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -58.8%
- 5-Year CAGR
- -11.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- Yubo International Biotech Ltd's pp&e (net) has declined for 3 consecutive years.
- 5-year CAGR of -11.5%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 79.1% year-over-year.
- Peak pp&e (net) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $43.0K | -79.1% |
| FY2024 | $205.9K | -45.1% |
| FY2023 | $375.2K | -39.2% |
| FY2022 | $616.7K | +679.1% |
| FY2020 | $79.2K | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |